CDC STI Treatment Guidelines: Gonorrhea, Chlamydia | March 17, 2022
Date of Presentation: March 17, 2022
Type: Past Presentation
Audience: Clinical
Program: Infectious Disease
Keywords: #cdc #chlamydia #covid-19 #gonorrhea #pid #std presentation #sti #trichomonas
In this series of presentations, Dr. Jorge Mera, ECHO Medical Director, provides a clinical update on emerging COVID-19 topics. Then, Dr. Hilary Reno, Medical Consultant for the CDC, discusses updated STI screening recommendations for special populations, reviews new recommended treatments for gonorrhea and chlamydia and updated guidelines regarding pelvic inflammatory disease and trichomonas management, and discusses follow-up care and some aspects of partner services.
Recording:
Presented by:
Dr. Hilary Reno, MD, PhD | Dr. Jorge Mera, MD
Dr. Hilary Reno is a Medical Consultant for the CDC, DSTDP. She also serves as Medical Director for the St. Louis County Sexual Health Clinic and StL STI/HIV PTC, and as Associate Professor for the Washington U in St. Louis.
Dr. Jorge Mera is the Director of Infectious Diseases for Cherokee Nation Health Services (CNHS), the largest tribally operated health care system in the United States. He completed his fellowship in Infectious Diseases and Clinical Microbiology at Baylor College of Medicine in Houston, Texas and is Board Certified by the American Board of Internal Medicine (ABIM) in Infectious Diseases. During recent years Jorge’s efforts have been dedicated to organizing the Cherokee Nation HCV elimination program, as well as the HIV/HCV ECHO project. He is also the Director of the HIV clinic since 2012 and the Principal Investigator of the End the HIV Epidemic for the CNHS. He is a Clinical Assistant Professor in the Department of Internal Medicine of the Oklahoma State University Health Science Center and a Fellow of the American College of Physicians.
Resources Provided:
- To Claim CE
- Sexually Transmitted Infections Treatment Guidelines, 2021 (CDC)
- Update to CDC's Treatment Guidelines for Gonococcal Infection, 2020 (MMWR)
- Azithromycin versus Doxycycline for Urogenital Chlamydia trachomatis Infection (NEJM)
- Treatment Effectiveness of Azithromycin and Doxycycline in Uncomplicated Rectal and Vaginal Chlamydia trachomatis Infections in Women: A Multicenter Observational Study (Clin Infectious Diseases)
- Azithromycin or Doxycycline for Asymptomatic Rectal Chlamydia trachomatis (NEJM)
- A Randomized Controlled Trial of Ceftriaxone and Doxycycline, With or Without Metronidazole, for the Treatment of Acute Pelvic Inflammatory Disease (Clin Infectious Diseases)
- STI National Strategic Plan Overview
- Key Updates in the 2021 CDC STI Treatment Guidelines: Gonorrhea, Chlamydia (Presentation Slides)
- COVID-19 Update (Presentation Slides)
Date added: March 16, 2022